NIH to Evaluate Iclaprim Activity against Listeria

    NEXT STORY
    The World Market for Orphan Drugs (2019-2023): Emergence of Combination Therapies & Novel Targets Spurs Market Growth
    PREV STORY
    Generex Biotechnology Announces Plans for NuGenerex Immuno-Oncology Spinout through a Targeted Acquisition of a Public Company and Planned Merger with Kiromic
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    MolecularMD is acquired by ICON

    author_avatar
    NASDAQ Market News

    GENFIT: Contributing Significantly to the European LITMUS Initiative on NASH Biomarkers

    GENFIT: Contributing Significantly to the European LITMUS Initiative on NASH Biomarkers GENFIT significantly contributes ...

    author_avatar
    NASDAQ Market News

    Precision Therapeutics Forms TumorGenesis Inc. Subsidiary to Focus on the Next Generation of Patient Derived Tumor Models

    MINNEAPOLIS, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the ...

    author_avatar
    NASDAQ Market News